1. Home
  2. PBYI vs EPSM Comparison

PBYI vs EPSM Comparison

Compare PBYI & EPSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • EPSM
  • Stock Information
  • Founded
  • PBYI 2010
  • EPSM 2010
  • Country
  • PBYI United States
  • EPSM China
  • Employees
  • PBYI N/A
  • EPSM N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • EPSM
  • Sector
  • PBYI Health Care
  • EPSM
  • Exchange
  • PBYI Nasdaq
  • EPSM Nasdaq
  • Market Cap
  • PBYI 167.3M
  • EPSM 185.6M
  • IPO Year
  • PBYI N/A
  • EPSM 2025
  • Fundamental
  • Price
  • PBYI $3.24
  • EPSM $23.67
  • Analyst Decision
  • PBYI Strong Buy
  • EPSM
  • Analyst Count
  • PBYI 1
  • EPSM 0
  • Target Price
  • PBYI $7.00
  • EPSM N/A
  • AVG Volume (30 Days)
  • PBYI 347.1K
  • EPSM 207.7K
  • Earning Date
  • PBYI 07-31-2025
  • EPSM 01-01-0001
  • Dividend Yield
  • PBYI N/A
  • EPSM N/A
  • EPS Growth
  • PBYI 143.51
  • EPSM N/A
  • EPS
  • PBYI 0.77
  • EPSM 0.02
  • Revenue
  • PBYI $232,709,000.00
  • EPSM $12,518,070.00
  • Revenue This Year
  • PBYI N/A
  • EPSM N/A
  • Revenue Next Year
  • PBYI N/A
  • EPSM N/A
  • P/E Ratio
  • PBYI $4.40
  • EPSM $1,062.40
  • Revenue Growth
  • PBYI 2.68
  • EPSM N/A
  • 52 Week Low
  • PBYI $2.23
  • EPSM $4.23
  • 52 Week High
  • PBYI $4.13
  • EPSM $27.00
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 50.17
  • EPSM N/A
  • Support Level
  • PBYI $3.38
  • EPSM N/A
  • Resistance Level
  • PBYI $3.70
  • EPSM N/A
  • Average True Range (ATR)
  • PBYI 0.18
  • EPSM 0.00
  • MACD
  • PBYI -0.03
  • EPSM 0.00
  • Stochastic Oscillator
  • PBYI 35.82
  • EPSM 0.00

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About EPSM Epsium Enterprise Limited Ordinary Shares

Epsium Enterprise Ltd is a holding company and conducts business through its subsidiaries. It is engaged in import trading and wholesale selling of beverages in Macau. The company imports and sells a range of beverages, alcoholic beverages, and a small quantity of tea and fruit juice. The alcoholic beverages it sells include Chinese liquor, French cognac, Scottish whiskey, fine wine, Champagne, and other miscellaneous beverage alcohol.

Share on Social Networks: